Finally, the data presented here show that mucosal CD4+ T cell homeostasis prior to infection can have far-reaching effects on an individual’s ability to control viral rebound during ATI, suggesting that monitoring and maintaining the Th17/Treg ratio may be key to the success of immune-based HIV cure strategies. This evidence concerns the gene CD4 and infection.